RichardF.SpaideMD

Ophthalmology • New York, NY

Retinal Disease

Associate Clinical Professor, Ophthalmology, New York Medical College

Join to view full profile

Dr. Spaide is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Spaide's full profile

Already have an account?

Office
950 3rd Ave
# 3
New York, NY 10022
Phone+1 212-861-9797

Fax+1 212-628-0698

Education & Training

Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 1989 - 1990
New York Medical College at St Vincent's Hospital and Medical Center of New YorkResidency, Ophthalmology, 1982 - 1985
Chestnut Hill HospitalInternship, Transitional Year, 1981 - 1982
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1981

Certifications & Licensure

NY State Medical License 1985 - 2025
PA State Medical License 1981 - 1982
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2014
Top Doctors: New York Metro Area Castle Connolly, 2002-2014
New York Magazine: Top Doctors Castle Connolly, 2012-2013
Super Doctor SuperDoctors.com
Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FAAO) American Academy of Ophthalmology
Join now to see all

Clinical Trials

Study Of Combined VISUDYNE Therapy With Kenalog In CNV Secondary To Age-Related Macular Degeneration Start of enrollment: 2003 Oct 01
Completed
Phase 2
Intravitreal Ranibizumab Treatment of Central Retinal Vein Occlusion With Macular Edema Start of enrollment: 2006 Nov 01
Completed
Phase 1
Imatinib Mesylate Combined With Intravitreal Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Age-Related Macular Degeneration Start of enrollment: 2006 Nov 01
Withdrawn
Phase 1
Intravitreal Ranibizumab Treatment of Central Serous Chorioretinopathy Start of enrollment: 2006 Aug 01
Completed
Phase 1
Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy Start of enrollment: 2007 May 01
Completed
Phase 1, Phase 2
Open Label to Study to Evaluate Effect of Alfilbercept on Patients With (FVPED) Fibrovascular Pigment Epithelial Detachment Start of enrollment: 2011 Dec 01
Withdrawn
Phase 4
Join now to see all

Publications & Presentations

PubMed

196 citations
Retinal Vasculitis and Intraocular Inflammation after Intravitreal Injection of Brolucizumab.
Caroline R. Baumal, Richard F. Spaide, Lejla Vajzovic, K. Bailey Freund, Scott D. Walter
Ophthalmology. 2020-04-25
128 citations
Acquired Vitelliform Lesions: correlation of clinical findings and multiple imaging analyses.
K. Bailey Freund, Ketan Laud, Luiz H. Lima, Richard F. Spaide, Sandrine Zweifel
Retina. 2011-01-01
238 citations
Optical Coherence Tomography Angiography Signs of Vascular Abnormalization With Antiangiogenic Therapy for Choroidal Neovascularization.
Richard F. Spaide
American Journal of Ophthalmology. 2015-07-01

Journal Articles

Optical Coherence Tomography Angiography
Nadia K Waheed, James G Fujimoto, Richard F Spaide, Srinivas R Sadda, ScienceDirect

Press Mentions

RETINA CONVERSATIONS: A Conversation with Namrata Saroj, ODApril 1st, 2019
Club Drug 'Poppers' May Pose Eye DangersApril 10th, 2017
Retina Subspecialty Day: Video AbstractsJune 7th, 2016

Professional Memberships

American Academy of Ophthalmology - AAO
Fellow

Other Languages

Spanish, Russian, Polish, Ukrainian